- Report
- April 2026
- 143 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- September 2026
- 183 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 180 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 188 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- January 2026
- 188 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- January 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- March 2026
- 150 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Report
- July 2026
- 160 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2026
- 189 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- May 2026
- 156 Pages
Global
From €3631EUR$3,950USD£3,087GBP
- Report
- April 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- October 2025
- 150 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- July 2026
- 95 Pages
North America
From €4366EUR$4,750USD£3,712GBP
- Report
- September 2026
France
From €4411EUR$4,799USD£3,751GBP
- Report
- September 2026
India
From €4411EUR$4,799USD£3,751GBP

Yttrium-90 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the treatment of cancer, as well as other diseases, and is produced in nuclear reactors. Yttrium-90 is used in a variety of medical applications, including targeted radiotherapy, radioembolization, and radioimmunotherapy. It is also used in the diagnosis of certain diseases, such as liver cancer.
Yttrium-90 is produced in a variety of forms, including microspheres, nanospheres, and liquid formulations. It is also available in a variety of formulations, including capsules, tablets, and injectables.
The Yttrium-90 market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Nordion, Eckert & Ziegler, IBA Molecular, and Advanced Accelerator Applications. Show Less Read more